Glaucus said it was overvalued by 77% so it’s approaching fair value? That’s at ~3.10 btw... It’s a punt.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025